"Genomics Market by Product & Service (System & Software, Consumables, Services), Technology (Sequencing, PCR), Application (Drug Discovery & Development, Diagnostic, Agriculture), End User (Hospital & Clinics, Research Centers) – Global Forecast to 2025", published by MarketsandMarkets™, the global Genomics Market is projected to reach USD 54.4 billion by 2025 from USD 22.7 billion in 2020, at a CAGR of 19.0% during the forecast period.
Browse in-depth TOC on "Genomics
Market"
114 – Tables
34 – Figures
194 – Pages
Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=613
Scope
of the Report:
The study categorizes the market into the following
segments and subsegments:
By
Product & Service
- Systems & Software
- Consumables
- Services
By
Technology
- Sequencing
- PCR
- Nucleic Acid Extraction and
Purification
- Microarray
- Other Technologies
By
Application
- Drug Discovery and Development
- Diagnostics
- Agriculture and Animal Research
- Other Applications
By
End User
- Hospitals &
Clinics
- Research Centers and Academic
& Government Institutes,
- Pharmaceutical &
Biotechnology Companies
- Other End Users
By
Region
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Rest of the World
- Latin America
- The Middle East and Africa
The major factors driving the growth of this market
include the increasing government funding to support genomics projects, the
growing incidence of cancer and increasing applications of NGS in cancer
research, the entry of new players and start-ups in the genomics product and
service market, and the growing application areas of genomics.
The next generation sequencing sub segment accounted
for the largest share of the sequencing technology segment in the genomics
market in 2019.
Based on technology, the market is segmented into
sequencing technologies, PCR, nucleic acid extraction and purification,
microarrays, and other technologies. The sequencing segment is further sub
segmented into next-generation sequencing (NGS) and other sequencing
technologies. In 2019 the next-generation sequencing technology accounted for
the largest share of the genomics market. The advantages associated with NGS
such as ultra-high-throughput, scalability, and high speed, enable researchers
to perform a wide variety of applications, including animal breeding,
agriculture, and human genomics. This is one of the major drivers of this
segment.
The hospitals and clinics segment accounted for the
largest share of the end user segment in the genomics product
and service market in 2019.
Based on end users, the genomics market is segmented
into hospitals & clinics, research centers and academic & government
institutes, pharmaceutical & biotechnology companies, and other end users.
In 2019, the hospitals & clinics segment accounted for the largest share of
the market. Hospitals & clinics are shifting from traditional genomic
testing methods to cost-effective and more sensitive methods, such as
whole-exome sequencing, which is a major factor driving the market growth.
Inquiry Before Buying: -https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=613
The Asia
Pacific region is the fastest growing region of the
genomics market in 2019.
In 2019, the Asia
Pacific region accented for the fastest growing region
of the market. It is also estimated to grow at the highest CAGR in the genomics
product and service market during the forecast period, mainly due to favorable
government support for genomics projects, increasing awareness about newer
genomics technologies such as NGS, and expansions of key players to strengthen
their presence in the APAC region.
Some of the leading players operating in the
genomics product and service market are Illumina, Inc. (US), Thermo Fisher
Scientific (US), QIAGEN N.V. (Netherlands),
Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland),
Bio-Rad Laboratories, Inc. (US), and BGI (China).
No comments:
Post a Comment